MDWD
MediWound Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$13.34
+0.98%Year over year
Reported trailing growth
- Revenue
- -40.3%
- EBITDA
- +26.0%
- EBIT
- -43.8%
- EPS
- +39.4%
- Free cash flow
- -47.3%
- Operating cash flow
- -44.2%
Forward estimates
Based on analyst estimates
- Revenue
- +188.1%
- EBITDA
- -49.4%
- EPS
- -55.9%
Three-year CAGR
- Revenue
- -13.8%
- EBITDA
- +23.1%
- EBIT
- -30.4%
- Net income
- +21.0%
- EPS
- +30.7%
- Free cash flow
- -0.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026